Merck To Buy Biotech Co. Millipore For $7.2B

Law360, New York (March 1, 2010, 2:41 PM EST) -- Merck KGaA has agreed to acquire biotechnology company Millipore Corp. for $7.2 billion, a move the German pharmaceutical giant says will bolster its laboratory equipment business.

Under the terms of the deal, announced Sunday, Merck will acquire all outstanding shares of Billerica, Mass.-based Millipore for $107 per share in cash, according to the companies.

The transaction has already received the blessing of boards of directors for both companies, they added.

“This transaction is very attractive to shareholders, customers and employees of both companies,” said Dr. Karl-Ludwig...
To view the full article, register now.